NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

市場調查報告書

全球免疫細胞治療市場分析(2021年):新型冠狀病毒感染疾病(COVID-19)造成的成長和變化(到2030年)

Cellular Immunotherapy Global Market Report 2021: COVID 19 Growth And Change to 2030

出版商 The Business Research Company 商品編碼 1009562
出版日期 按訂單生產 內容資訊 英文 175 Pages
商品交期: 2-10個工作天內
價格
全球免疫細胞治療市場分析(2021年):新型冠狀病毒感染疾病(COVID-19)造成的成長和變化(到2030年) Cellular Immunotherapy Global Market Report 2021: COVID 19 Growth And Change to 2030
出版日期: 按訂單生產內容資訊: 英文 175 Pages
簡介

本報告提供全球免疫細胞治療市場相關調查,提供市場概要,市場區隔·各地區的市場規模的變化與預測,新型冠狀病毒感染疾病(COVID-19)對市場的影響,市場成長的推動要素及阻礙因素分析,競爭情形,主要企業的簡介等全面性資訊。

目錄

第1章 摘要整理

第2章 市場特徵

第3章 市場趨勢與策略

第4章 新型冠狀病毒感染疾病(COVID-19)的影響

第5章 市場規模與成長

  • 全球免疫細胞治療市場(實際成果值)
    • 市場推動要素
    • 市場阻礙因素
  • 全球免疫細胞治療市場(預測值)
    • 市場推動要素
    • 市場阻礙因素

第6章 免疫細胞治療市場:各市場區隔

  • 市場區隔:各治療法(實際成果值·預測值)
    • TIL療法
    • TCR基因治療
    • CAR-T細胞療法
    • 自然殺手細胞療法
  • 市場區隔:主要各適應症(實際成果值·預測值)
    • B細胞惡性腫瘤
    • 前列腺癌症
    • 腎細胞癌症
    • 肝臟癌症
    • 非何杰金氏淋巴瘤
    • 其他
  • 市場區隔:各用途(實際成果值·預測值)
    • 前列腺癌症
    • 乳癌
    • 皮膚癌症
    • 卵巢癌症
    • 腦瘤
    • 肺癌症
    • 其他

第7章 免疫細胞治療市場:各地各國

  • 市場規模:各地區(實際成果值·預測值)
  • 市場規模:各國(實際成果值·預測值)

第8章 亞太地區的免疫細胞治療市場

  • 市場概要
  • 地區/市場資訊·COVID-19的影響·政府措施·規定·公司稅結構·投資·主要企業等
  • 市場規模:各治療法(實際成果值·預測值)
  • 市場規模:各用途(實際成果值·預測值)

第9章 中國的免疫細胞治療市場

  • 市場概要
  • 市場規模:各治療法(實際成果值·預測值)
  • 市場規模:各用途(實際成果值·預測值)

第10章 印度的免疫細胞治療市場

  • 市場規模:各治療法(實際成果值·預測值)
  • 市場規模:各用途(實際成果值·預測值)

第11章 日本的免疫細胞治療市場

  • 市場規模:各治療法(實際成果值·預測值)
  • 市場規模:各用途(實際成果值·預測值)

第12章 澳洲的免疫細胞治療市場

  • 市場規模:各治療法(實際成果值·預測值)
  • 市場規模:各用途(實際成果值·預測值)

第13章 印尼的免疫細胞治療市場

  • 市場規模:各治療法(實際成果值·預測值)
  • 市場規模:各用途(實際成果值·預測值)

第14章 韓國的免疫細胞治療市場

  • 市場規模:各治療法(實際成果值·預測值)
  • 市場規模:各用途(實際成果值·預測值)

第15章 西歐的免疫細胞治療市場

  • 市場概要
  • 市場規模:各治療法(實際成果值·預測值)
  • 市場規模:各用途(實際成果值·預測值)

第16章 英國的免疫細胞治療市場

  • 市場規模:各治療法(實際成果值·預測值)
  • 市場規模:各用途(實際成果值·預測值)

第17章 德國的免疫細胞治療市場

  • 市場規模:各治療法(實際成果值·預測值)
  • 市場規模:各用途(實際成果值·預測值)

第18章 法國的免疫細胞治療市場

  • 市場規模:各治療法(實際成果值·預測值)
  • 市場規模:各用途(實際成果值·預測值)

第19章 東歐的免疫細胞治療市場

  • 市場概要
  • 市場規模:各治療法(實際成果值·預測值)
  • 市場規模:各用途(實際成果值·預測值)

第20章 俄羅斯的免疫細胞治療市場

  • 市場規模:各治療法(實際成果值·預測值)
  • 市場規模:各用途(實際成果值·預測值)

第21章 北美的免疫細胞治療市場

  • 市場概要
  • 市場規模:各治療法(實際成果值·預測值)
  • 市場規模:各用途(實際成果值·預測值)

第22章 美國的免疫細胞治療市場

  • 市場規模:各治療法(實際成果值·預測值)
  • 市場規模:各用途(實際成果值·預測值)

第23章 南美的免疫細胞治療市場

  • 市場概要
  • 市場規模:各治療法(實際成果值·預測值)
  • 市場規模:各用途(實際成果值·預測值)

第24章 巴西的免疫細胞治療市場

  • 市場規模:各治療法(實際成果值·預測值)
  • 市場規模:各用途(實際成果值·預測值)

第25章 中東的免疫細胞治療市場

  • 市場概要
  • 市場規模:各治療法(實際成果值·預測值)
  • 市場規模:各用途(實際成果值·預測值)

第26章 非洲的免疫細胞治療市場

  • 市場概要
  • 市場規模:各治療法(實際成果值·預測值)
  • 市場規模:各用途(實際成果值·預測值)

第27章 競爭情形和企業簡介

  • 競爭情形
  • 企業簡介
    • Novartis AG
    • Gilead Sciences Inc. (Kite Pharma)
    • Apac Biotech
    • Dendreon Pharmaceuticals LLC
    • JW CreaGene Co. Ltd

第28章 開發平台分析

第29章 主要合併·收購

第30章 未來預測與潛在性分析

第31章 附錄

目錄

Cellular Immunotherapy Global Market Report 2021: COVID 19 Growth And Change to 2030 from The Business Research Company provides the strategists, marketers and senior management with the critical information they need to assess the global cellular immunotherapy market.

This report focuses on cellular immunotherapy market which is experiencing strong growth. The report gives a guide to the cellular immunotherapy market which will be shaping and changing our lives over the next ten years and beyond, including the markets response to the challenge of the global pandemic.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 12+ geographies.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order.

Where is the largest and fastest growing market for the cellular immunotherapy ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The Cellular Immunotherapy market global report from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography. It places the market within the context of the wider cellular immunotherapy market, and compares it with other markets.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, the influence of the Covid 19 virus and forecasting its growth.
  • Market segmentations break down market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of Covid 19 for all regions, key developed countries and major emerging markets.
  • Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
  • The cellular immunotherapy market section of the report gives context. It compares the cellular immunotherapy market with other segments of the cellular immunotherapy market by size and growth, historic and forecast. It analyses GDP proportion, expenditure per capita, cellular immunotherapy indicators comparison.

Scope

Markets Covered: 1) By Therapy: Tumour-Infiltrating Lymphocyte (TIL) Therapy; Engineered T Cell Receptor (TCR) Therapy; Chimeric Antigen Receptor (CAR) T Cell Therapy; Natural Killer (NK) Cell Therapy

2) By Primary Indication: B-cell Malignancies; Prostate Cancer; Renal Cell Carcinoma; Liver Cancer; Non-Hodgkin lymphoma; Others

3) By Application: Prostate Cancer; Breast Cancer; Skin Cancer; Ovarian Cancer; Brain Tumour; Lung Cancer; Others

Companies Mentioned: Novartis AG; Gilead Sciences Inc. (Kite Pharma); Apac Biotech; Dendreon Pharmaceuticals LLC; JW CreaGene Co. Ltd

Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Table of Contents

1. Executive Summary

2. Cellular Immunotherapy Market Characteristics

3. Cellular Immunotherapy Market Trends And Strategies

4. Impact Of COVID-19 On Cellular Immunotherapy

5. Cellular Immunotherapy Market Size And Growth

  • 5.1. Global Cellular Immunotherapy Historic Market, 2015-2020, $ Billion
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints On The Market
  • 5.2. Global Cellular Immunotherapy Forecast Market, 2020-2025F, 2030F, $ Billion
    • 5.2.1. Drivers Of The Market
    • 5.2.2. Restraints On the Market

6. Cellular Immunotherapy Market Segmentation

  • 6.1. Global Cellular Immunotherapy Market, Segmentation By Therapy, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Tumour-Infiltrating Lymphocyte (TIL) Therapy
  • Engineered T Cell Receptor (TCR) Therapy
  • Chimeric Antigen Receptor (CAR)
  • T Cell Therapy
  • Natural Killer (NK) Cell Therapy
  • 6.2. Global Cellular Immunotherapy Market, Segmentation By Primary Indication, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • B-cell Malignancies
  • Prostate Cancer
  • Renal Cell Carcinoma
  • Liver Cancer
  • Non-Hodgkin lymphoma
  • Others 3
  • 6.3. Global Cellular Immunotherapy Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Prostate Cancer
  • Breast Cancer
  • Skin Cancer
  • Ovarian Cancer
  • Brain Tumour
  • Lung Cancer
  • Others

7. Cellular Immunotherapy Market Regional And Country Analysis

  • 7.1. Global Cellular Immunotherapy Market, Split By Region, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 7.2. Global Cellular Immunotherapy Market, Split By Country, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

8. Asia-Pacific Cellular Immunotherapy Market

  • 8.1. Asia-Pacific Cellular Immunotherapy Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Cellular Immunotherapy Market, Segmentation By Therapy, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 8.3. Asia-Pacific Cellular Immunotherapy Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

9. China Cellular Immunotherapy Market

  • 9.1. China Cellular Immunotherapy Market Overview
  • 9.2. China Cellular Immunotherapy Market, Segmentation By Therapy, Historic and Forecast, 2015-2020, 2020-2025F, 2030F,$ Billion
  • 9.3. China Cellular Immunotherapy Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F,$ Billion

10. India Cellular Immunotherapy Market

  • 10.1. India Cellular Immunotherapy Market, Segmentation By Therapy, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 10.2. India Cellular Immunotherapy Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

11. Japan Cellular Immunotherapy Market

  • 11.1. Japan Cellular Immunotherapy Market, Segmentation By Therapy, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 11.2. Japan Cellular Immunotherapy Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

12. Australia Cellular Immunotherapy Market

  • 12.1. Australia Cellular Immunotherapy Market, Segmentation By Therapy, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 12.2. Australia Cellular Immunotherapy Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

13. Indonesia Cellular Immunotherapy Market

  • 13.1. Indonesia Cellular Immunotherapy Market, Segmentation By Therapy, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 13.2. Indonesia Cellular Immunotherapy Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

14. South Korea Cellular Immunotherapy Market

  • 14.1. South Korea Cellular Immunotherapy Market, Segmentation By Therapy, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 14.2. South Korea Cellular Immunotherapy Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

15. Western Europe Cellular Immunotherapy Market

  • 15.1. Western Europe Cellular Immunotherapy Market Overview
  • 15.2. Western Europe Cellular Immunotherapy Market, Segmentation By Therapy, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 15.3. Western Europe Cellular Immunotherapy Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

16. UK Cellular Immunotherapy Market

  • 16.1. UK Cellular Immunotherapy Market, Segmentation By Therapy, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 16.2. UK Cellular Immunotherapy Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

17. Germany Cellular Immunotherapy Market

  • 17.1. Germany Cellular Immunotherapy Market, Segmentation By Therapy, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 17.2. Germany Cellular Immunotherapy Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

18. France Cellular Immunotherapy Market

  • 18.4. France Cellular Immunotherapy Market, Segmentation By Therapy, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 18.5. France Cellular Immunotherapy Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

19. Eastern Europe Cellular Immunotherapy Market

  • 19.1. Eastern Europe Cellular Immunotherapy Market Overview
  • 19.2. Eastern Europe Cellular Immunotherapy Market, Segmentation By Therapy, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 19.3. Eastern Europe Cellular Immunotherapy Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

20. Russia Cellular Immunotherapy Market

  • 20.1. Russia Cellular Immunotherapy Market, Segmentation By Therapy, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 20.2. Russia Cellular Immunotherapy Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

21. North America Cellular Immunotherapy Market

  • 21.1. North America Cellular Immunotherapy Market Overview
  • 21.2. North America Cellular Immunotherapy Market, Segmentation By Therapy, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 21.3. North America Cellular Immunotherapy Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

22. USA Cellular Immunotherapy Market

  • 22.1. USA Cellular Immunotherapy Market Overview
  • 22.2. USA Cellular Immunotherapy Market, Segmentation By Therapy, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 22.3. USA Cellular Immunotherapy Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

23. South America Cellular Immunotherapy Market

  • 23.1. South America Cellular Immunotherapy Market Overview
  • 23.2. South America Cellular Immunotherapy Market, Segmentation By Therapy, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 23.3. South America Cellular Immunotherapy Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

24. Brazil Cellular Immunotherapy Market

  • 24.1. Brazil Cellular Immunotherapy Market, Segmentation By Therapy, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 24.2. Brazil Cellular Immunotherapy Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

25. Middle East Cellular Immunotherapy Market

  • 25.1. Middle East Cellular Immunotherapy Market Overview
  • 25.2. Middle East Cellular Immunotherapy Market, Segmentation By Therapy, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 25.3. Middle East Cellular Immunotherapy Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

26. Africa Cellular Immunotherapy Market

  • 26.1. Africa Cellular Immunotherapy Market Overview
  • 26.2. Africa Cellular Immunotherapy Market, Segmentation By Therapy, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 26.3. Africa Cellular Immunotherapy Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

27. Cellular Immunotherapy Market Competitive Landscape And Company Profiles

  • 27.1. Cellular Immunotherapy Market Competitive Landscape
  • 27.2. Cellular Immunotherapy Market Company Profiles
    • 27.2.1. Novartis AG
      • 27.2.1.1. Overview
      • 27.2.1.2. Products and Services
      • 27.2.1.3. Strategy
      • 27.2.1.4. Financial Performance
    • 27.2.2. Gilead Sciences Inc. (Kite Pharma)
      • 27.2.2.1. Overview
      • 27.2.2.2. Products and Services
      • 27.2.2.3. Strategy
      • 27.2.2.4. Financial Performance
    • 27.2.3. Apac Biotech
      • 27.2.3.1. Overview
      • 27.2.3.2. Products and Services
      • 27.2.3.3. Strategy
      • 27.2.3.4. Financial Performance
    • 27.2.4. Dendreon Pharmaceuticals LLC
      • 27.2.4.1. Overview
      • 27.2.4.2. Products and Services
      • 27.2.4.3. Strategy
      • 27.2.4.4. Financial Performance
    • 27.2.5. JW CreaGene Co. Ltd
      • 27.2.5.1. Overview
      • 27.2.5.2. Products and Services
      • 27.2.5.3. Strategy
      • 27.2.5.4. Financial Performance

28. Cellular Immunotherapy Pipeline Analysis

29. Key Mergers And Acquisitions In The Cellular Immunotherapy Market

30. Cellular Immunotherapy Market Future Outlook and Potential Analysis

31. Appendix

  • 31.1. Abbreviations
  • 31.2. Currencies
  • 31.3. Research Inquiries
  • 31.4. The Business Research Company
  • 31.5. Copyright And Disclaimer